S. Gertler

2.1k total citations
37 papers, 1.5k citations indexed

About

S. Gertler is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, S. Gertler has authored 37 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 14 papers in Pulmonary and Respiratory Medicine and 7 papers in Genetics. Recurrent topics in S. Gertler's work include Cancer Treatment and Pharmacology (9 papers), Glioma Diagnosis and Treatment (6 papers) and Lung Cancer Treatments and Mutations (6 papers). S. Gertler is often cited by papers focused on Cancer Treatment and Pharmacology (9 papers), Glioma Diagnosis and Treatment (6 papers) and Lung Cancer Treatments and Mutations (6 papers). S. Gertler collaborates with scholars based in Canada, United States and United Kingdom. S. Gertler's co-authors include Alan Webster, Matthew J. Ellis, Aman U. Buzdar, John Pippen, Charles Morris, Stephen E. Jones, Isaiah W. Dimery, G. Burton, SE Come and L M Parker and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Neuroscience.

In The Last Decade

S. Gertler

37 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Gertler Canada 16 909 600 513 364 278 37 1.5k
Kelly Pendergrass United States 19 1.1k 1.2× 320 0.5× 808 1.6× 355 1.0× 369 1.3× 31 2.3k
Mary Anne Rossing United States 22 931 1.0× 617 1.0× 209 0.4× 535 1.5× 489 1.8× 32 2.5k
Yuri Yamaguchi Japan 22 534 0.6× 679 1.1× 212 0.4× 373 1.0× 778 2.8× 52 1.9k
Xiaohong R. Yang United States 28 1.2k 1.3× 483 0.8× 555 1.1× 866 2.4× 788 2.8× 106 2.7k
Hiroshi Sonoo Japan 26 1.3k 1.5× 476 0.8× 292 0.6× 645 1.8× 820 2.9× 123 2.3k
Debra Black Australia 9 689 0.8× 1.0k 1.7× 121 0.2× 378 1.0× 474 1.7× 15 2.0k
Marina Elena Cazzaniga Italy 28 2.1k 2.3× 308 0.5× 639 1.2× 609 1.7× 540 1.9× 138 3.2k
M. Mesiti Italy 17 676 0.7× 723 1.2× 250 0.5× 623 1.7× 161 0.6× 59 1.4k
Rachel L. Yung United States 15 695 0.8× 245 0.4× 228 0.4× 559 1.5× 566 2.0× 35 1.8k
Luigi Celio Italy 22 1.2k 1.4× 465 0.8× 351 0.7× 383 1.1× 244 0.9× 82 2.2k

Countries citing papers authored by S. Gertler

Since Specialization
Citations

This map shows the geographic impact of S. Gertler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Gertler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Gertler more than expected).

Fields of papers citing papers by S. Gertler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Gertler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Gertler. The network helps show where S. Gertler may publish in the future.

Co-authorship network of co-authors of S. Gertler

This figure shows the co-authorship network connecting the top 25 collaborators of S. Gertler. A scholar is included among the top collaborators of S. Gertler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Gertler. S. Gertler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
LeVasseur, Nathalie, Carol Stober, S. Gertler, et al.. (2018). Perceptions of Vascular Access for Intravenous Systemic Therapy and Risk Factors for Lymphedema in Early-Stage Breast Cancer—A Patient Survey. Current Oncology. 25(4). 305–310. 23 indexed citations
2.
Ibrahim, Mohammed, John Hilton, Sasha Mazzarello, et al.. (2017). A multi-center pragmatic, randomized, feasibility trial comparing standard of care schedules of filgrastim administration for primary febrile neutropenia prophylaxis in early-stage breast cancer. Breast Cancer Research and Treatment. 168(2). 371–379. 7 indexed citations
3.
Arnaout, Angel, Iryna Kuchuk, Nathaniel Bouganim, et al.. (2016). Can the Referring Surgeon Enhance Accrual of Breast Cancer Patients to Medical and Radiation Oncology Trials? The Enhance Study. Current Oncology. 23(3). 276–279. 10 indexed citations
4.
5.
Addison, Christina, Nathaniel Bouganim, John Hilton, et al.. (2014). A phase II, multicentre trial evaluating the efficacy of de-escalated bisphosphonate therapy in metastatic breast cancer patients at low-risk of skeletal-related events. Breast Cancer Research and Treatment. 144(3). 615–624. 21 indexed citations
6.
Jacobs, Carmel, Iryna Kuchuk, Stephanie Smith, et al.. (2014). A randomized, double-blind trial evaluating the palliative benefit of either continuing pamidronate or switching to zoledronate in patients with high-risk bone metastases from breast cancer (The Odyssey Study).. Journal of Clinical Oncology. 32(31_suppl). 155–155. 1 indexed citations
7.
Kuchuk, Iryna, Nathaniel Bouganim, Lisa Vandermeer, et al.. (2013). Preference weights for chemotherapy side effects from the perspective of women with breast cancer. Breast Cancer Research and Treatment. 142(1). 101–107. 71 indexed citations
8.
Frechette, Dominique, Lise Paquet, Shailendra Verma, et al.. (2013). The impact of endocrine therapy on sexual dysfunction in postmenopausal women with early stage breast cancer: encouraging results from a prospective study. Breast Cancer Research and Treatment. 141(1). 111–117. 36 indexed citations
9.
Kuchuk, Iryna, Nathaniel Bouganim, Lisa Vandermeer, et al.. (2013). Patient perceptions about potential side effects and benefits from chemotherapy agents.. Journal of Clinical Oncology. 31(15_suppl). 6595–6595. 6 indexed citations
10.
Dent, Susan, S. Gertler, Shailendra Verma, et al.. (2009). A phase II study of biweekly pemetrexed and gemcitabine in patients with metastatic breast cancer. Cancer Chemotherapy and Pharmacology. 65(3). 557–561. 3 indexed citations
11.
Webster, Marc, Gregory Cairncross, S. Gertler, et al.. (2005). Phase II Trial of SarCNU in Malignant Glioma: Unexpected Pulmonary Toxicity with a Novel Nitrosourea. Investigational New Drugs. 23(6). 591–596. 5 indexed citations
12.
Kirby, Sarah, S. Gertler, Warren Mason, et al.. (2005). Phase 2 study of T138067-sodium in patients with malignant glioma: Trialof the National Cancer Institute of Canada Clinical Trials Group. Neuro-Oncology. 7(2). 183–188. 20 indexed citations
13.
Gelmon, Karen A., John R. Mackey, Shailendra Verma, et al.. (2004). Use of Trastuzumab Beyond Disease Progression: Observations from a Retrospective Review of Case Histories. Clinical Breast Cancer. 5(1). 52–58. 104 indexed citations
14.
Bélanger, Karl, David R. Macdonald, Gregory Cairncross, et al.. (2003). A phase II study of topotecan in patients with anaplastic oligodendroglioma or anaplastic mixed oligoastrocytoma. Investigational New Drugs. 21(4). 473–480. 3 indexed citations
15.
Robertson, J.F.R., C. Kent Osborne, Anthony Howell, et al.. (2003). Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma in postmenopausal women. Cancer. 98(2). 229–238. 241 indexed citations
16.
Watters, James M., Jonathan C. Yau, Keith O’Rourke, Eva Tomiak, & S. Gertler. (2003). Functional status is well maintained in older women during adjuvant chemotherapy for breast cancer. Annals of Oncology. 14(12). 1744–1750. 34 indexed citations
17.
Earle, Craig C., David J. Stewart, Yvon Cormier, et al.. (1998). A phase I study of gemcitabine/cisplatin/etoposide in the treatment of small-cell lung cancer. Lung Cancer. 22(3). 235–241. 9 indexed citations
18.
Evans, William K., Craig C. Earle, David J. Stewart, et al.. (1997). Phase II study of a one hour paclitaxel infusion in combination with carboplatin for advanced non-small cell lung cancer. Lung Cancer. 18(1). 83–94. 12 indexed citations
19.
20.
Mahadevan, Mani S., et al.. (1988). Evaluation of four commercially available assays for free thyroxin.. Clinical Chemistry. 34(11). 2302–2307. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kelly Pendergrass Breakdown of academic impact, for papers by Mary Anne Rossing Breakdown of academic impact, for papers by Yuri Yamaguchi Breakdown of academic impact, for papers by Xiaohong R. Yang Breakdown of academic impact, for papers by Hiroshi Sonoo Breakdown of academic impact, for papers by Debra Black Breakdown of academic impact, for papers by Marina Elena Cazzaniga Breakdown of academic impact, for papers by M. Mesiti Breakdown of academic impact, for papers by Rachel L. Yung Breakdown of academic impact, for papers by Luigi Celio
Rankless by CCL
2026